Mark D DeBoer1, David R Weber1, Babette S Zemel1, Michelle R Denburg1, Rita Herskovitz1, Jin Long1, Mary B Leonard1. 1. Department of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
Abstract
CONTEXT: Rapid bone accrual and calcium demands during puberty may result in compensatory increases in PTH and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels; however, these relations have not been established in longitudinal studies. OBJECTIVE: To determine whether greater bone accrual velocity is associated with greater PTH and 1,25(OH)2D levels in healthy children and adolescents. DESIGN: Prospective cohort study with baseline PTH, 25-hydroxyvitamin D [25(OH)D], and 1,25(OH)2D levels and dual-energy x-ray absorptiometry whole-body bone mineral content (BMC) accrual over 12 months. Secondary analyses examined bone biomarkers and tibia quantitative computed tomography midshaft cortical-BMC. PARTICIPANTS: A total of 594 healthy participants, ages 5-21 years, with longitudinal measures in a subset of 145 participants. MAIN OUTCOME MEASURES: PTH and 1,25(OH)2D levels. RESULTS: PTH levels were higher during Tanner stages 3 and 4 compared to Tanner 1 (P < .05) in males and females and were inversely and significantly associated with 25(OH)D levels and dietary calcium intake. In multivariable analyses, greater bone accrual [measured directly as change in dual-energy x-ray absorptiometry-BMC (P < .001) or quantitative computed tomography-BMC (P < .05), or indirectly as growth velocity (P < .05) or greater bone-formation biomarker level (P < .01)] was associated with higher PTH levels, independent of 25(OH)D level and dietary calcium intake. Similar associations were observed between these direct and indirect indices of bone accrual and 1,25(OH)2D levels. CONCLUSIONS: PTH levels rise in midpuberty, in association with multiple measures of bone accrual. This is consistent with compensatory increases in PTH to drive 1,25(OH)2D production and calcium absorption during periods of increased calcium demands. Additional studies are needed to address PTH effects on bone modeling and remodeling during growth and development.
CONTEXT: Rapid bone accrual and calcium demands during puberty may result in compensatory increases in PTH and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels; however, these relations have not been established in longitudinal studies. OBJECTIVE: To determine whether greater bone accrual velocity is associated with greater PTH and 1,25(OH)2D levels in healthy children and adolescents. DESIGN: Prospective cohort study with baseline PTH, 25-hydroxyvitamin D [25(OH)D], and 1,25(OH)2D levels and dual-energy x-ray absorptiometry whole-body bone mineral content (BMC) accrual over 12 months. Secondary analyses examined bone biomarkers and tibia quantitative computed tomography midshaft cortical-BMC. PARTICIPANTS: A total of 594 healthy participants, ages 5-21 years, with longitudinal measures in a subset of 145 participants. MAIN OUTCOME MEASURES: PTH and 1,25(OH)2D levels. RESULTS: PTH levels were higher during Tanner stages 3 and 4 compared to Tanner 1 (P < .05) in males and females and were inversely and significantly associated with 25(OH)D levels and dietary calcium intake. In multivariable analyses, greater bone accrual [measured directly as change in dual-energy x-ray absorptiometry-BMC (P < .001) or quantitative computed tomography-BMC (P < .05), or indirectly as growth velocity (P < .05) or greater bone-formation biomarker level (P < .01)] was associated with higher PTH levels, independent of 25(OH)D level and dietary calcium intake. Similar associations were observed between these direct and indirect indices of bone accrual and 1,25(OH)2D levels. CONCLUSIONS: PTH levels rise in midpuberty, in association with multiple measures of bone accrual. This is consistent with compensatory increases in PTH to drive 1,25(OH)2D production and calcium absorption during periods of increased calcium demands. Additional studies are needed to address PTH effects on bone modeling and remodeling during growth and development.
Authors: Marianne V Augustine; Mary B Leonard; Meena Thayu; Robert N Baldassano; Ian H de Boer; Justine Shults; Lee A Denson; Mark D DeBoer; Rita Herskovitz; Michelle R Denburg Journal: J Clin Endocrinol Metab Date: 2014-03-11 Impact factor: 5.958
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: S J Warden; K M Hill; A J Ferira; E M Laing; B R Martin; D B Hausman; C M Weaver; M Peacock; R D Lewis Journal: Osteoporos Int Date: 2012-10-24 Impact factor: 4.507
Authors: Lindsay M Griffin; Meena Thayu; Robert N Baldassano; Mark D DeBoer; Babette S Zemel; Michelle R Denburg; Lee A Denson; Justine Shults; Rita Herskovitz; Jin Long; Mary B Leonard Journal: J Clin Endocrinol Metab Date: 2015-04-28 Impact factor: 5.958
Authors: Mark D DeBoer; Arthur M Lee; Kirabo Herbert; Jin Long; Meena Thayu; Lindsay M Griffin; Robert N Baldassano; Lee A Denson; Babette S Zemel; Michelle R Denburg; Rita Herskovitz; Mary B Leonard Journal: J Clin Endocrinol Metab Date: 2018-03-01 Impact factor: 5.958
Authors: Denise L Jacobson; Charles B Stephensen; Tracie L Miller; Kunjal Patel; Janet S Chen; Russell B Van Dyke; Ayesha Mirza; Gertrud U Schuster; Rohan Hazra; Angela Ellis; Sean S Brummel; Mitchell E Geffner; Margarita Silio; Stephen A Spector; Linda A DiMeglio Journal: J Acquir Immune Defic Syndr Date: 2017-09-01 Impact factor: 3.731